FDA Approves GLP-1 pill, Foundayo, for Weight Loss

Health & LifestyleNews
351

Listen to article (english)

Translate to Spanish or other 102 languages!

The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problem. Image for illustration purposes
The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problem. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems.

This approval makes Eli Lilly’s oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug available in pill form, after Wegovy, which gained approval in December 2025.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/fda-approves-oral-glp-1-pill-foundayo-for-weight-loss

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Texas AG Opens New Medicaid Fraud Investigations Based on Newly Released Federal Data
Next article
Cold, Flu, or Allergies? Key Differences to Watch For

More Articles

From Classroom to Career: TSC Apprentices Take Next Step Toward Certification

Apprentices in Texas Southmost College’s Early Childhood and Phlebotomy Apprenticeship Programs took an important step toward completing their apprenticeships when they received Occupational Skills Awards (OSA) during a ceremony held September 12 at the ITEC Center. 

STHS Tackles Childhood Asthma in New Episode

If your child frequently experiences coughing, wheezing or shortness of breath, particularly during physical activity, they may be among the millions of young people living with asthma.

McAllen Cancer Survivor Takes Her Fight for Patients to Washington

For breast cancer survivor Elvia Gibbs, traveling from McAllen to Washington, D.C., was about more than advocating for legislation. It was an opportunity to tell lawmakers firsthand that cancer research and access to clinical trials can mean more time, hope, and quality of life for patients.

Changing Careers, Changing Lives: TSC Student Receives Prestigious Grant

Texas Southmost College student Eleazar Hernandez is blazing a trail as a standout in the college’s Respiratory Care Science program, earning recognition for his work at both the regional and statewide levels for his academic and research achievements. 
- Advertisement -